BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25547827)

  • 1. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential biomarker expression in head and neck cancer correlates with anatomical localization.
    Tamás L; Szentkúti G; Eros M; Dános K; Brauswetter D; Szende B; Zsákovics I; Krenács T
    Pathol Oncol Res; 2011 Sep; 17(3):721-7. PubMed ID: 21487776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
    Zhang Q; Zhang W; Zhang J; Xu H; You Y
    Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
    Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
    Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
    Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K
    Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas.
    Yuen PW; Man M; Lam KY; Kwong YL
    J Clin Pathol; 2002 Jan; 55(1):58-60. PubMed ID: 11825926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
    Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
    Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
    Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
    Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
    Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression.
    Rittà M; De Andrea M; Mondini M; Mazibrada J; Giordano C; Pecorari G; Garzaro M; Landolfo V; Schena M; Chiusa L; Landolfo S
    Head Neck; 2009 Mar; 31(3):318-27. PubMed ID: 19072995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
    Kalfert D; Celakovsky P; Laco J; Ludvikova M
    Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.